Current Research Initiatives

We are proud to support several ongoing, collaborative translational and clinical research initiatives to find cures  for Crohn’s disease and ulcerative colitis, along with improved diagnostics, and treatments for inflammatory bowel disease (IBD).

Our partners include scientists, clinicians, research centers, universities, medical centers and government health organizations.

Please explore our groundbreaking initiatives to learn more about the broad range of IBD research programs that we support and how you can become more involved.

Research Overview

We invite you to dig deeper into each of our IBD research initiatives:

 

Genetics Initiative

A collaborative initiative to study the genetic component of IBD and find gene pathways that may help in the design of new IBD medications.

 

Microbiome Initiative

A multi-institutional project to identify, compare, and analyze intestinal microbial agents to study the causes of IBD in hopes of one day developing cures.

 

Environmental Triggers

An initiative to study the genetic and environmental factors that may contribute to IBD, including viruses, smoking, diet, and psychological stress.

 

Novel Technologies

An initiative to explore advanced technologies, such as imaging and sensor technologies, surgical tools, and implantable devices, along with regenerative medicine and stem cell-based technology.

 

Pediatric RISK Stratification

A study to identify the genetic, microbiological, and immunological factors in children to predict which children may develop serious complications that will require surgery.

 

IBD Plexus®

The largest and most interconnected data and research information platform in IBD that brings researchers and investigators together to develop better treatments and a cure.

 

Clinical Research Networks

A collaboration of major medical centers and smaller, local facilities working on clinical studies of the management and treatment of IBD.

 

IBD Partners

A patient-powered research network that connects patients and researchers, and allows patients to ask questions, propose research ideas, and share their experiences with IBD.